Avoro Capital Advisors LLC - LION BIOTECHNOLOGIES INC ownership

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of LION BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2017$33,908,000
+7.9%
4,551,343
+0.7%
4.33%
-31.7%
Q4 2016$31,418,000
-10.3%
4,520,643
+6.2%
6.35%
+3.2%
Q3 2016$35,038,000
-0.3%
4,257,347
-1.9%
6.15%
-21.3%
Q2 2016$35,142,000
+121.4%
4,338,557
+38.8%
7.81%
+41.0%
Q1 2016$15,876,000
-35.5%
3,125,198
-2.0%
5.54%
-34.7%
Q4 2015$24,608,000
+34.3%
3,187,607
+0.2%
8.48%
+78.0%
Q3 2015$18,322,000
-31.6%
3,180,913
+8.8%
4.76%
-35.5%
Q2 2015$26,805,000
+3.0%
2,923,065
+36.0%
7.38%
-26.1%
Q1 2015$26,035,0002,149,9079.99%
Other shareholders
LION BIOTECHNOLOGIES INC shareholders Q2 2017
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,188,331$15,209,00019.14%
ACUTA CAPITAL PARTNERS, LLC 3,809,944$26,479,0009.85%
Avoro Capital Advisors LLC 4,520,643$31,418,0006.35%
Broadfin Capital, LLC 2,638,259$18,336,0002.04%
Perceptive Advisors 3,567,553$24,794,0001.76%
Ghost Tree Capital, LLC 975,000$6,776,0001.63%
Opaleye Management Inc. 300,000$2,085,0001.23%
Rhenman & Partners Asset Management AB 650,000$4,518,0000.87%
ACUTA CAPITAL PARTNERS, LLC 150,000$1,043,0000.39%
QVT Financial LP 1,498,809$10,349,0000.31%
View complete list of LION BIOTECHNOLOGIES INC shareholders